DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 05 · Volume 37 · September 2004 DOI: 10.1055/s-002-3589

Original Paper

Original Paper

193
E , Kuenzel H.; H , Murck; K , Held; M , Ziegenbein; A , Steiger: Reboxetine Induces Similar Sleep-EEG Changes Like SSRI’s in Patients with Depression
206
Bertani, A.; Perna, G.; Migliarese, G.; Di Pasquale, D.; Cucchi, M.; Caldirola, D.; Bellodi, L.: Comparison of the Treatment with Paroxetine and Reboxetine in Panic Disorder: A Randomized, Single-Blind Study
211
Klumpers, U. M. H.; Boom, K.; Janssen, F. M. G.; Tulen, J. H. M.; Loonen, A. J. M.: Cardiovascular Risk Factors in Outpatients with Bipolar Disorder

Letter

238
Lieb, K.; Walden, J.; Grunze, H.; Fiebich, B. L.; Berger, M.; Normann, C.: Serum Levels of Substance P and Response to Antidepressant Pharmacotherapy
242
Keszthelyi, Z.; Past, T.; Lukáts, B.; Koltai, K.; Karádi, Z.: The Central Effect of Chromium on Glucose Metabolism